Department of Psychiatry

Penn Behavioral Health

Research

The TMS program at the University of Pennsylvania is collaborating in various research studies that involve TMS treatment. Please click on the studies below to see a brief description and the contact numbers.

Comparing Effectiveness of Aripiprazole Augmentation, rTMS Augmentation, and Switching to Venlafaxine XR in Treatment Resistant Depression (ASCERTAIN-TRD)

 

 

 This clinical research study is a multi-site, randomized, open-label study designed to help us compare the efficacy of three treatment options for depression: a) aripiprazole added to the current antidepressant, b) rTMS added to the current antidepressant, and c) switching to venlafaxine XR.

If you are interested in participating or would like more information, please call (215) 898-4301 or email Bluemood@pennmedicine.upenn.edu

Close

Investigation of Mood and Behavior Circuits through Personalized TMS and Neuroimaging

The purpose of this study is to implement and develop neuroimaging methods for characterizing and treating psychological disorders. By using TMS in concurrence with MRI, this procedure will help develop a comprehensive understanding of TMS effects on brain circuitry.

If you are interested in participating or would like more information, please contact the Center for Neuromodulation in Depression and Stress (CNDS) Lab at 215-746-2637 or send an e-mail to CNDSlab@mail.med.upenn.edu

Close


Back to Top